These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2524533)

  • 1. Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366).
    Shlaes DM; Al-Obeid S; Shlaes JH; Williamson R
    J Infect Dis; 1989 Jun; 159(6):1132-5. PubMed ID: 2524533
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
    Leclercq R; Derlot E; Duval J; Courvalin P
    N Engl J Med; 1988 Jul; 319(3):157-61. PubMed ID: 2968517
    [No Abstract]   [Full Text] [Related]  

  • 3. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.
    Leclercq R; Derlot E; Weber M; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1989 Jan; 33(1):10-5. PubMed ID: 2523687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible carboxypeptidase activity in vancomycin-resistant enterococci.
    Gutmann L; Billot-Klein D; al-Obeid S; Klare I; Francoual S; Collatz E; van Heijenoort J
    Antimicrob Agents Chemother; 1992 Jan; 36(1):77-80. PubMed ID: 1534213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
    Greenwood D; Bidgood K; Turner M
    J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible resistance to vancomycin in Enterococcus faecium D366.
    Williamson R; Al-Obeid S; Shlaes JH; Goldstein FW; Shlaes DM
    J Infect Dis; 1989 Jun; 159(6):1095-104. PubMed ID: 2723455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.
    al-Obeid S; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1990 Feb; 34(2):252-6. PubMed ID: 2139314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.
    Nicas TI; Wu CY; Hobbs JN; Preston DA; Allen NE
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1121-4. PubMed ID: 2528940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
    Breyer S; Georgopoulos A; Graninger W
    Drugs Exp Clin Res; 1987; 13(8):479-81. PubMed ID: 2962843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
    O'Hare MD; Felmingham D; Grüneberg RN
    J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
    [No Abstract]   [Full Text] [Related]  

  • 15. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
    Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
    Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
    Bingen E; Lambert-Zechovsky N; Leclercq R; Doit C; Mariani-Kurkdjian P
    J Antimicrob Chemother; 1990 Nov; 26(5):619-26. PubMed ID: 1964156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC; Ribou G; Masquelier B
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.